 | • レポートコード：QFJ1-4362 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、感染症用診療現場診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（店頭（OTC）検査キット、処方箋ベース検査キット）、用途別市場規模（細菌感染症、真菌感染症、ウイルス感染症、心血管感染症、胃腸感染症、性感染症（STD）感染症、中枢神経系感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・感染症用診療現場診断の市場動向 ・企業の競争状況、市場シェア ・感染症用診療現場診断の種類別市場規模と予測2016-2027（店頭（OTC）検査キット、処方箋ベース検査キット） ・感染症用診療現場診断の用途別市場規模と予測2016-2027（細菌感染症、真菌感染症、ウイルス感染症、心血管感染症、胃腸感染症、性感染症（STD）感染症、中枢神経系感染症、その他） ・感染症用診療現場診断の北米市場規模2016-2027（アメリカ、カナダ） ・感染症用診療現場診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症用診療現場診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症用診療現場診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症用診療現場診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Siemens、GE Healthcare、Accriva、Terumo、BioMerieux、Diasorin、Roche、Danaher Corporation、BD、Bio-Rad Laboratories、Cavidi、Cepheid、Diaxonhit、Eiken Chemical、EMD Millipore、Epitope Diagnostic、Euroimmun、Gold Standard Diagnostics、Hologic、Immunetics、InBios International） ・結論 |
Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
Market Analysis and Insights: Global Infectious Disease Point of Care Diagnostics Market
The global Infectious Disease Point of Care Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Point of Care Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Point of Care Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Point of Care Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Point of Care Diagnostics market.
Global Infectious Disease Point of Care Diagnostics Scope and Market Size
Infectious Disease Point of Care Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Point of Care Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
Segment by Application
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Over-the-counter (OTC) Testing Kits
1.2.3 Prescription-based Testing Kits
1.3 Market by Application
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bacterial Infections
1.3.3 Fungal Infection
1.3.4 Virus Infection
1.3.5 Cardiovascular Infection
1.3.6 Gastrointestinal Infection
1.3.7 Sexually Transmitted Disease (STD) Infection
1.3.8 Central Nervous System Infection
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2016-2027)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Point of Care Diagnostics Industry Dynamic
2.3.1 Infectious Disease Point of Care Diagnostics Market Trends
2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2020
3.5 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2022-2027)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2016-2027)
6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type
6.2.1 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2027)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Application
6.3.1 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2027)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Country
6.4.1 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2016-2027)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
7.2.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application
7.3.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Country
7.4.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Disease Point of Care Diagnostics Market Size (2016-2027)
9.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type
9.2.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application
9.3.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country
9.4.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.2.5 Siemens Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Accriva
11.4.1 Accriva Company Details
11.4.2 Accriva Business Overview
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.4.5 Accriva Recent Development
11.5 Terumo
11.5.1 Terumo Company Details
11.5.2 Terumo Business Overview
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.5.5 Terumo Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.6.5 BioMerieux Recent Development
11.7 Diasorin
11.7.1 Diasorin Company Details
11.7.2 Diasorin Business Overview
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.7.5 Diasorin Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Details
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.9.5 Danaher Corporation Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.10.5 BD Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Cavidi
11.12.1 Cavidi Company Details
11.12.2 Cavidi Business Overview
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.12.5 Cavidi Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.13.5 Cepheid Recent Development
11.14 Diaxonhit
11.14.1 Diaxonhit Company Details
11.14.2 Diaxonhit Business Overview
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.14.5 Diaxonhit Recent Development
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Details
11.15.2 Eiken Chemical Business Overview
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.15.5 Eiken Chemical Recent Development
11.16 EMD Millipore
11.16.1 EMD Millipore Company Details
11.16.2 EMD Millipore Business Overview
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.16.5 EMD Millipore Recent Development
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Details
11.17.2 Epitope Diagnostic Business Overview
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.17.5 Epitope Diagnostic Recent Development
11.18 Euroimmun
11.18.1 Euroimmun Company Details
11.18.2 Euroimmun Business Overview
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.18.5 Euroimmun Recent Development
11.18 Gold Standard Diagnostics
.1 Gold Standard Diagnostics Company Details
.2 Gold Standard Diagnostics Business Overview
.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
.5 Gold Standard Diagnostics Recent Development
11.20 Hologic
11.20.1 Hologic Company Details
11.20.2 Hologic Business Overview
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.20.5 Hologic Recent Development
11.21 Immunetics
11.21.1 Immunetics Company Details
11.21.2 Immunetics Business Overview
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.21.5 Immunetics Recent Development
11.22 InBios International
11.22.1 InBios International Company Details
11.22.2 InBios International Business Overview
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021)
11.22.5 InBios International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Over-the-counter (OTC) Testing Kits
Table 3. Key Players of Prescription-based Testing Kits
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2022-2027)
Table 10. Infectious Disease Point of Care Diagnostics Market Trends
Table 11. Infectious Disease Point of Care Diagnostics Market Drivers
Table 12. Infectious Disease Point of Care Diagnostics Market Challenges
Table 13. Infectious Disease Point of Care Diagnostics Market Restraints
Table 14. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2020)
Table 17. Ranking of Global Top Infectious Disease Point of Care Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Infectious Disease Point of Care Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
Table 21. Date of Enter into Infectious Disease Point of Care Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Infectious Disease Point of Care Diagnostics Product
Table 64. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Siemens Company Details
Table 67. Siemens Business Overview
Table 68. Siemens Infectious Disease Point of Care Diagnostics Product
Table 69. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Siemens Recent Development
Table 71. GE Healthcare Company Details
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Infectious Disease Point of Care Diagnostics Product
Table 74. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Accriva Company Details
Table 77. Accriva Business Overview
Table 78. Accriva Infectious Disease Point of Care Diagnostics Product
Table 79. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Accriva Recent Development
Table 81. Terumo Company Details
Table 82. Terumo Business Overview
Table 83. Terumo Infectious Disease Point of Care Diagnostics Product
Table 84. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Terumo Recent Development
Table 86. BioMerieux Company Details
Table 87. BioMerieux Business Overview
Table 88. BioMerieux Infectious Disease Point of Care Diagnostics Product
Table 89. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 90. BioMerieux Recent Development
Table 91. Diasorin Company Details
Table 92. Diasorin Business Overview
Table 93. Diasorin Infectious Disease Point of Care Diagnostics Product
Table 94. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Diasorin Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Roche Recent Development
Table 100. Danaher Corporation Company Details
Table 101. Danaher Corporation Business Overview
Table 102. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
Table 103. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Danaher Corporation Recent Development
Table 105. BD Company Details
Table 106. BD Business Overview
Table 107. BD Infectious Disease Point of Care Diagnostics Product
Table 108. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 109. BD Recent Development
Table 110. Bio-Rad Laboratories Company Details
Table 111. Bio-Rad Laboratories Business Overview
Table 112. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product
Table 113. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Bio-Rad Laboratories Recent Development
Table 115. Cavidi Company Details
Table 116. Cavidi Business Overview
Table 117. Cavidi Infectious Disease Point of Care Diagnostics Product
Table 118. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Cavidi Recent Development
Table 120. Cepheid Company Details
Table 121. Cepheid Business Overview
Table 122. Cepheid Infectious Disease Point of Care Diagnostics Product
Table 123. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 124. Cepheid Recent Development
Table 125. Diaxonhit Company Details
Table 126. Diaxonhit Business Overview
Table 127. Diaxonhit Infectious Disease Point of Care Diagnostics Product
Table 128. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Diaxonhit Recent Development
Table 130. Eiken Chemical Company Details
Table 131. Eiken Chemical Business Overview
Table 132. Eiken Chemical Infectious Disease Point of Care Diagnostics Product
Table 133. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 134. Eiken Chemical Recent Development
Table 135. EMD Millipore Company Details
Table 136. EMD Millipore Business Overview
Table 137. EMD Millipore Infectious Disease Point of Care Diagnostics Product
Table 138. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 139. EMD Millipore Recent Development
Table 140. Epitope Diagnostic Company Details
Table 141. Epitope Diagnostic Business Overview
Table 142. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product
Table 143. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 144. Epitope Diagnostic Recent Development
Table 145. Euroimmun Company Details
Table 146. Euroimmun Business Overview
Table 147. Euroimmun Infectious Disease Point of Care Diagnostics Product
Table 148. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 149. Euroimmun Recent Development
Table 150. Gold Standard Diagnostics Company Details
Table 151. Gold Standard Diagnostics Business Overview
Table 152. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product
Table 153. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 154. Gold Standard Diagnostics Recent Development
Table 155. Hologic Company Details
Table 156. Hologic Business Overview
Table 157. Hologic Infectious Disease Point of Care Diagnostics Product
Table 158. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 159. Hologic Recent Development
Table 160. Immunetics Company Details
Table 161. Immunetics Business Overview
Table 162. Immunetics Infectious Disease Point of Care Diagnostics Product
Table 163. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 164. Immunetics Recent Development
Table 165. InBios International Company Details
Table 166. InBios International Business Overview
Table 167. InBios International Infectious Disease Point of Care Diagnostics Product
Table 168. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2016-2021) & (US$ Million)
Table 169. InBios International Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Over-the-counter (OTC) Testing Kits Features
Figure 3. Prescription-based Testing Kits Features
Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Bacterial Infections Case Studies
Figure 6. Fungal Infection Case Studies
Figure 7. Virus Infection Case Studies
Figure 8. Cardiovascular Infection Case Studies
Figure 9. Gastrointestinal Infection Case Studies
Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 11. Central Nervous System Infection Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Regions: 2020 VS 2027
Figure 17. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2022-2027)
Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2020
Figure 19. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2020
Figure 21. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2016-2021)
Figure 22. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2022-2027)
Figure 23. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2027)
Figure 25. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2027)
Figure 26. North America Infectious Disease Point of Care Diagnostics Market Share by Country (2016-2027)
Figure 27. United States Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2027)
Figure 31. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2027)
Figure 32. Europe Infectious Disease Point of Care Diagnostics Market Share by Country (2016-2027)
Figure 33. Germany Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Region (2016-2027)
Figure 43. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2027)
Figure 51. Latin America Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2027)
Figure 52. Latin America Infectious Disease Point of Care Diagnostics Market Share by Country (2016-2027)
Figure 53. Mexico Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Country (2016-2027)
Figure 59. Turkey Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 63. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 64. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 65. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 66. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 67. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 68. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 70. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 71. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 73. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 74. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 75. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 76. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 77. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 78. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 79. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 80. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 81. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 82. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 83. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2016-2021)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
世界のポイントオブケア感染症市場規模・現状・予測（2021年-2027年） A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management. Market Analysis and Insights: Global Point…- 世界のポイントオブケア感染管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point Of Care Infection Control Market The global Point Of Care Infection Control market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
- 世界の寄生虫感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parasitic Infection Testing Market The global Parasitic Infection Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界の医療関連感染症診断市場規模・現状・予測（2021年-2027年） Diagnosis of health care-associated infectious diseases. Diagnosis of health care-associated infectious diseases. Market Analysis and Insights: Global Healthcare-associated Infectious Disease Diagnostics Market The global Healthcare-associated Infectious Disease Diagnostics market size is projected …
- 感染症検査機器のグローバル市場2021 Infectious Disease Testing Instrumentation is a kind of instrument to diagnose infectious disease, such as HIV, HCV, HBV, HAV, CMV, HPV and so on. In the last several years, China market of Infectious Disease Testing Instrumentation developed year by year, with an average growth rate of 17.36% for t…